Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| ASML Holding NV | 2.09% | $123.13M | €351.20B | 38.18% | 78 Outperform | |
| SAP SE | 1.48% | $87.04M | €261.78B | 4.56% | 73 Outperform | |
| Nestlé SA | 1.34% | $78.92M | CHF198.32B | 2.56% | 65 Neutral | |
| AstraZeneca | 1.33% | $78.20M | £194.71B | 7.56% | 75 Outperform | |
| Novartis AG | 1.25% | $73.81M | CHF187.47B | 3.69% | 78 Outperform | |
| Roche Holding AG | 1.21% | $71.35M | CHF208.68B | 3.87% | 73 Outperform | |
| Toyota Motor | 1.20% | $70.80M | ¥41.00T | 17.17% | 81 Outperform | |
| HSBC Holdings | 1.18% | $69.71M | £184.65B | 52.00% | 79 Outperform | |
| Shell (UK) | 1.13% | $66.84M | £165.60B | 14.14% | 77 Outperform | |
| Siemens | 1.05% | $62.01M | €192.47B | 35.64% | 74 Outperform |